Latest Strategic Reset News

Retail Food Group Limited demonstrated resilience in FY25 with slight sales growth and strategic expansions, setting a positive tone for FY26. Key brand innovations and franchisee support underpin its growth trajectory amid leadership transition.

Lifestyle Communities Limited reported a challenging FY25 marked by a significant $135.5 million after-tax write-down following a VCAT ruling, while signaling early signs of recovery and strategic reset for FY26.

Apiam Animal Health reported a challenging FY25 with underperformance in its core clinical segment but has rebounded strongly in Q1 FY26. The company is now poised for acquisition by Adamantem Capital, offering shareholders a premium cash and scrip deal.

Nufarm’s FY25 results reveal robust growth in crop protection and a strategic reset in seed technologies, with a significant reduction in net debt setting the stage for a stronger FY26.

Nufarm reported a mixed FY25 with strong crop protection profits offset by a statutory loss from seed restructuring, while targeting earnings growth and debt reduction in FY26.

KMD Brands reported a challenging FY25 with a net loss but has launched a transformative ‘Next Level’ strategy focused on cost reset, product innovation, and digital growth. Early FY26 trading shows promising sales momentum, signaling potential turnaround.

Energy World Corporation Ltd has outlined a strategic reset including a $442 million debt-to-equity conversion and is progressing towards commissioning its flagship Pagbilao LNG and power project in the Philippines, alongside advancing its Sengkang LNG facility in Indonesia.

Genetic Signatures Limited unveiled a year of strategic transformation and robust financial growth at its 2025 AGM, highlighting leadership renewal and a sharpened commercial focus. The company’s FY25 revenue jumped 66%, driven by strong product demand and expanded market presence.

Camplify Holdings reported a $15.8 million net loss for FY25 amid strategic consolidation and tech integration, while launching its MyWay membership model to drive future profitability.

Invex Therapeutics has appointed two new non-executive directors and joint company secretaries, signaling a refreshed governance structure alongside a change of company address.

ANZ reported a 10% decline in statutory profit for FY2025, impacted by significant regulatory and restructuring charges, while reaffirming its ANZ 2030 strategy and maintaining a strong capital position.

Epsilon Healthcare has commenced operations of its new pharmacy division and extended a key loan facility, signaling a strategic pivot towards integrated healthcare and financial stability after recent restructuring.